Corona virus and HIV
It is the same department in hospital that treats both HIV and Covid-19, this department is therefore very busy these days. Everyone living with HIV can rest assure that they will receive the necessary treatment, renewal of prescriptions etc.
labelEmner: Corona viruscovid-19
The outpatient clinic at Ullevål University Hospital has implemented digital solutions for their patients living with HIV. HivNorway is in regular contact with the department and will regularly post new information on our website.
People who have recently been diagnosed with HIV and are awaiting test results from Ullevål sykehus will be followed up as soon as their results are available.
A small number of people living with HIV have continuously low CD4 numbers, and can have a suppressed immune system, which makes them more vulnerable for respiratory infections. HivNorway have been contacted repeatedly with questions about HIV being one of the groups especially at risk. The Department Head of the Department for Infectious Diseases at Ullevål answers as follows:
HIV is at the 17th of March 2020 not defined as a special risk to get infected by or get a serious infection by Covid-19.
It is assumed that people with very low CD4-numbers (below 200) will be vulnerable to Covid-19 infection. If this applies to you please take extra care in adhering to the advice of The Institute for Public Health’s advice to avoid infection.
These are the at risk groups:
· Age over 65 years
· Heart and coronary disease
· Respiratory disease
· High blood-pressure
· It is possible that smoking gives an extra vulnerability for infection.
A lot is still uncertain. The Norwegian Institute for Public Health continuously updates this website with information about and for groups at risk.
It is not necessary to disclose your HIV status to your employee or others in connection with a potential infection if you do not want to.
Here you can read the Norwegian Institute for Public Health’s general advice for the population about corona and the situation in Norway. If you have a fever, or respiratory issues, call your general practioner. It is important that you do not go directly to your doctor’s office without an appointment. Call the emergency room at 116 117 outside office hours.
Treating Covid-19 with HIV medication
Trials are now being conducted were Covid-19 is treated with HIV medication. People living with HIV no longer commonly use the types of medication used in these trials. The Health Authorities assures us that these trials will in no way impact people living with HIVs access to their medication.
There is also no information that suggest that people living with HIV cannot be infected by COvid-19 or be a carrier of the virus because of their HIV treatment.
Pneumococcal conjugate vaccine
At risk groups have been recommended to take a vaccine against pneumonia caused by the pneumococcal bacteria. There is no relation to the Corona virus, but will assist health services by reducing the number of cases of this pneumonia needing treatment.
Pneumococcal conjugate vaccine is offered to everyone living with HIV at their initial controls with their infectious disease specialist. That means that most already have been offered this vaccine. There is now a shortage of the vaccine, and it will only be offered to people whom have not taken the vaccine, and are part of the risk groups.
The outpatient clinic at OUS is now offering the vaccine to all their patients who have never taken it and is over the age of 65 years.
If you have other questions or need to talk with someone, please contact us at +47 21 31 45 80 or +47 920 16 892, through social media or by mail email@example.com.
→ Nytt styre i HivNorge
Årsmøtet i HivNorge som ble avholdt 23. mars, valgte nytt styre og ny styreleder. Leif-Ove Hansen overlater stafettpinnen til Roger Dybedahl.
→ Årsrapporten over seksuelt overførbare infeksjoner er klar
Folkehelseinstituttet lanserte i dag sin årlige rapport om overvåkning over seksuelt overførbare sykdommer i Norge. Dette inkluderer en oversikt over hivsituasjonen i Norge i 2022. Effektive tiltak som tidlig diagnostikk, vellykket hivbehandling og den hivforebyggende behandlingen PrEP, har resultert i et lavt antall personer som er smittet i Norge, med en nedgang på 80% de siste ti årene.